The effect of calcimimetics on complications of chronic kidney disease

The effect of calcimimetics on complications of chronic kidney disease - The effect of calcimimetics on complications of chronic kidney disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035414

Enrollment

100

Registered

2018-12-30

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease(CKD)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic kidney disease patients who are visiting our hospital regularly

Exclusion criteria

Exclusion criteria: Patients complicated with serious diseases such as malignancy, heart failure (NYHA III degrees or more), and liver cirrhosis

Design outcomes

Primary

Measure	Time frame
Investigation of the effect of calcimimetics on bone and mineral metabolism factor, bone density, parathyroid enlargement in CKD patients	—

Secondary

Measure	Time frame
Effects of calcimimetics on cardiac function and bone metabolism markers in CKD patients	—

Countries

Japan

Contacts

Public ContactMichio Kuwahara

Saitama Tsukinomori Clinic Division of Nephrology

kuwahara@k-naika-cl.jp0487921811

Outcome results